All In Biotech

Drug Trial Radar · NCT00474630

A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes

A Multicenter, Randomized, Double Blind, Placebo Controlled Study Comparing the Safety and Efficacy of Naltrexone 32 mg Sustained Release (SR)/Bupropion 360 mg Sustained Release (SR) and Placebo in Obese Subjects With Type 2 Diabetes Mellitus

Last checked: Nov 20, 2026Latest source record: Nov 21, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 505 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

505

Actual

Start

May 2007

Primary completion

Jun 2009

Study completion Jun 2009

Sponsor

Lead sponsor
Orexigen Therapeutics, IncIndustry
Sponsor type
Industry
First posted
May 17, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is determine whether the combination of naltrexone SR and bupropion SR is safe and effective in treating obesity in subjects with type 2 diabetes.

Conditions

  • Obesity
  • Overweight
  • Diabetes Mellitus, Type 2

Interventions

  • Naltrexone SR 32 mg/bupropion SR 360 mg/ dayDrug

  • PlaceboDrug

  • Ancillary therapyBehavioral

    Ancillary therapy consisting of diet instruction, advice on behavior modification, and exercise counseling

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Co-primary: Body Weight- Mean Percent ChangeTime frame: Baseline, 56 weeks
  2. Co-primary: Body Weight- Proportion of Subjects With ≥5% DecreaseTime frame: Baseline, 56 weeks

Locations

53 sites in 1 country. Site status is shown where the registry gives one.

  • SelfCenter, PC

    Fairhope, Alabama

  • Pivotal Research Centers

    Peoria, Arizona

  • HOPE Research Institute

    Phoenix, Arizona

  • HealthStar Research

    Hot Springs, Arkansas

  • Impact Clinical Trials

    Beverly Hills, California

  • Northern California Research

    Carmichael, California

  • Sierra Medical Research

    Fresno, California

  • Advance Clinical Research Institute

    Orange, California

  • Affiliated Research Institute

    San Diego, California

  • VA San Diego Healthcare System

    San Diego, California

  • Apex Research Institue

    Santa Ana, California

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • LCFP Inc.

    Fort Myers, Florida

  • Miami Research Associates

    Miami, Florida

  • Suncoast Clinical Research

    Palm Harbor, Florida

  • University Clinical Research

    Pembroke Pines, Florida

  • CSRA Partners in Health, Inc

    Augusta, Georgia

  • East-West Medical Research Institute

    Honolulu, Hawaii

  • Deaconess Clinic

    Evansville, Indiana

  • Northwest Indiana Center for Clinical Research

    Valparaiso, Indiana

  • Central Kentucky Research Associates, Inc.

    Lexington, Kentucky

  • L-Marc

    Louisville, Kentucky

  • Trover Center for Clinical Studies

    Madisonville, Kentucky

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana

  • Medical Research Institute

    Slidell, Louisiana

  • Health Trends Research, LLC

    Baltimore, Maryland

  • FutureCare Studies

    Springfield, Massachusetts

  • Twin Cities Clinical Research

    Brooklyn Center, Minnesota

  • The Center for Pharmaceutical Research

    Kansas City, Missouri

  • Mercy Health Research

    St Louis, Missouri

  • Radiant Research, Inc.

    St Louis, Missouri

  • Center for Nutrition and Metabolic Diseases, Univ. of Nevada

    Reno, Nevada

  • Endocrinology & Diabetes Consultants

    Dover, New Hampshire

  • Lovelace Scientific Resources

    Albuquerque, New Mexico

  • Diabetes care and Information Center

    Flushing, New York

  • Central New York Clinical Research

    Manlius, New York

  • Rochester Clinical Research, Inc

    Rochester, New York

  • Metrolina Medical Research

    Charlotte, North Carolina

  • Rapid Medical Research, Inc.

    Cleveland, Ohio

  • Central Ohio Nutrition Center, Inc.

    Columbus, Ohio

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.